Abiopharma

🔍 Friesner Richard (Director)

Company: Schrodinger, Inc. (SDGR)

Report Date: 2026-06-26

Detailed Transactions and Holdings:

• Sold 679,373 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: G | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
• Acquired 679,373 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: G | equity_swap_involved: 0 | shares_owned_after: 679,373.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: H | nature_of_ownership: By spouse | shares_owned_after: 28,328.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-26 | Code: H | shares_owned_after: 705,917.00 | Footnotes: F3

Footnotes:

• F1: Upon termination of the RF 2018 GRAT, 679,373 of the shares were transferred on June 26, 2026 to the RF 2018 Family Trust (the "Family Trust"). The remaining shares have been distributed to Dr. Friesner, trustee and sole annuitant of the RF 2018 GRAT, and are reported in this Form 4 as directly owned.
• F2: These shares are held by the Family Trust, of which Dr. Friesner's spouse is a trustee and Dr. Friesner's children are the beneficiaries. Dr. Friesner disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
• F3: Includes 8,141 unvested RSUs and 2,335 shares that were transferred from the RF 2018 GRAT to Dr. Friesner but were previously incorrectly reported as indirectly owned.